CNS Radiation-Related Adverse Events in Lung Cancer Patients Treated With PD-1/PD-L1 Inhibitors

被引：0
|
作者：
Hubbeling, H. [1 ]
Schapira, E. [1 ]
Shaw, A. [1 ]
Oh, K. S. [1 ]
Gainor, J. [1 ]
Shih, H. A. [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 99卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2017.06.349
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
324
引用
收藏
页码：S150 / S151
页数：2
相关论文
共 50 条
  • [31] Prognostic Significance of the Severity of Immune-Related Adverse Events in Advanced Cancer Patients Treated with PD-1/PD-L1 Inhibitors: A Real-World Data Analysis
    Song, Su Jeong
    Song, Yun-Kyoung
    Jang, Mihwa
    Shin, Eunjeong
    Suh, Sung Yun
    Cho, Yoon Sook
    Lee, Ju-Yeun
    Oh, Jung Mi
    [J]. TARGETED ONCOLOGY, 2023, 18 (01) : 147 - 158
  • [32] Prognostic Significance of the Severity of Immune-Related Adverse Events in Advanced Cancer Patients Treated with PD-1/PD-L1 Inhibitors: A Real-World Data Analysis
    Su Jeong Song
    Yun-Kyoung Song
    Mihwa Jang
    Eunjeong Shin
    Sung Yun Suh
    Yoon Sook Cho
    Ju-Yeun Lee
    Jung Mi Oh
    [J]. Targeted Oncology, 2023, 18 : 147 - 158
  • [33] Effectiveness of PD-1/PD-L1 inhibitors in the treatment of lung cancer: Brightness and challenge
    Ying Yang
    Yongfeng Yu
    Shun Lu
    [J]. Science China Life Sciences, 2020, 63 : 1499 - 1514
  • [34] Effectiveness of PD-1/PD-L1 inhibitors in the treatment of lung cancer: Brightness and challenge
    Ying Yang
    Yongfeng Yu
    Shun Lu
    [J]. Science China(Life Sciences)., 2020, 63 (10) - 1514
  • [35] Effectiveness of PD-1/PD-L1 inhibitors in the treatment of lung cancer: Brightness and challenge
    Ying Yang
    Yongfeng Yu
    Shun Lu
    [J]. Science China Life Sciences, 2020, (10) : 1499 - 1514
  • [36] Challenges to Biomarker Testing for PD-1/PD-L1 Checkpoint Inhibitors for Lung Cancer
    Cagle, Philip T.
    Bernicker, Eric H.
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2015, 139 (12) : 1477 - 1478
  • [37] Ongoing clinical trials of PD-1 and PD-L1 inhibitors for lung cancer in China
    Liu, Si-Yang
    Wu, Yi-Long
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10
  • [38] Ongoing clinical trials of PD-1 and PD-L1 inhibitors for lung cancer in China
    Si-Yang Liu
    Yi-Long Wu
    [J]. Journal of Hematology & Oncology, 10
  • [39] Effectiveness of PD-1/PD-L1 inhibitors in the treatment of lung cancer: Brightness and challenge
    Yang, Ying
    Yu, Yongfeng
    Lu, Shun
    [J]. SCIENCE CHINA-LIFE SCIENCES, 2020, 63 (10) : 1499 - 1514
  • [40] Cutaneous adverse events in patients treated with PD-1/PD-L1 checkpoint inhibitors and their association with survival: a systematic review and meta-analysis
    Zhao, Fangmin
    Zhu, Junjing
    Yu, Rui
    Shao, Tianyu
    Chen, Shuyi
    Zhang, Gaochenxi
    Shu, Qijin
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
12345